Facing challenges in starting a family? A groundbreaking university spin-out has just secured a substantial £3.5 million investment, aiming to revolutionize fertility treatments, making them both more successful and accessible. This innovative approach promises to reshape the landscape of in-vitro fertilization (IVF).
At the heart of this advancement is a tiny liquid circuit, a 'microfluidic' device, developed by IVFmicro. This device is designed to handle embryos and a small amount of fluid with incredible precision. It operates on a microscopic scale, moving and mixing liquids through channels smaller than a human hair, mirroring the body's natural environment.
Early trials are incredibly promising, suggesting that this technology can boost embryo quality and quantity by at least 15 percent. This represents a significant leap from the traditional 'petri dish' method, potentially leading to higher pregnancy rates and fewer treatment cycles for patients.
But here's where it gets controversial... This technology could dramatically increase the chances of a successful pregnancy by improving the number of viable embryos available for transfer. This also increases the likelihood of implantation, potentially reducing the emotional and financial burden on those seeking fertility treatments.
IVFmicro's journey began as a research project at Leeds University in 2017, spearheaded by Helen Picton, the company’s scientific director, and Virginia Pensabene, the chief executive. Picton, a professor specializing in reproduction and early development, brings extensive experience, including her involvement in helping the first woman have a baby from a frozen ovary. Pensabene, a biomedical engineer, is an expert in microfluidics, having used the technology to model human organs for drug testing.
Pensabene highlights the core issue: "We have been able to show that we can grow embryos and support their development much better than the standard methods." The current methods often start with a limited pool of embryos, many of which don’t develop to the quality needed for successful implantation.
The team's experiments with large animal embryos, which closely resemble human ones, have yielded impressive results. Using sheep, they've doubled the rate of embryo development and significantly increased pregnancy rates. This means if the initial implantation isn't successful, there are more high-quality embryos available for subsequent attempts.
And this is the part most people miss... The investment comes from Northern Gritstone, a firm that supports university spinouts and start-ups in the north of England, along with the government’s Innovate UK Investor Partnerships programme. Duncan Johnson, the chief executive of Northern Gritstone, calls IVFmicro a prime example of world-class innovation emerging from northern universities.
What are your thoughts? Do you believe this technology will make a real difference in the lives of those struggling with infertility? Could this be a turning point in fertility treatments, or are there potential drawbacks that need further consideration? Share your opinions in the comments below!
